CIK: 1951291 - Address: C/O Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego, CA 92130
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/24/24 18:18
4/23/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeM.d1391.060131112,866D
4/22/24 19:23
4/19/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeM.d2001.060188212,735I
4/17/24 18:42
4/16/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS-9289.280-100-112,546I
4/10/24 17:39
4/9/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS-9289.280-100-112,646I
3/26/24 18:47
3/22/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS.m-8909.120-98-112,746I
3/21/24 21:50
3/19/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS.m-229.030-2012,844I
3/15/24 19:52
3/13/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS.m-9149.140-100-112,846I
3/1/24 20:21
2/29/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS-349.020-4012,946I
2/28/24 21:08
2/26/24
SPRYArs Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTanimoto SarinaCAOTChief MeS.m-8979.020-99-112,950I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact